Loading...
Loading...
For most people, the word "wealth" conjures up a bank balance or a brokerage statement. But for the millions of workers at venture-backed startups, a huge portion of their net worth is locked inside paper that nobody can spend — vested stock options, restricted shares, or RSUs in a private company. The startup liquidity options for employees that exist today are dramatically different from what was available even five years ago, and most workers I talk to dramatically underestimate both their choices and their risks.
I've spent the better part of the past decade watching this market evolve. As a financial analyst covering secondary markets and alternative investment vehicles, I've seen quiet tender offers turn engineers into millionaires and watched late-stage employees walk away with nothing because they didn't understand how their post-termination exercise window worked. The good news in 2026 is that there are more legitimate paths than ever to access employee liquidity startup wealth. The bad news is that picking the wrong one — or doing nothing at all — can cost six or seven figures.
This article walks through the major liquidity choices available to startup employees today, the tradeoffs of each, and the practical considerations you'll want to weigh before you act.
The pace at which companies go public has slowed since the 2021 boom. According to coverage in Bloomberg and other financial outlets, the median time from founding to IPO has stretched well past a decade for U.S. tech companies, and the SPAC window that briefly opened around 2020-2022 has effectively closed for most growth-stage startups. That means employees are sitting on private shares for far longer than they used to, with strike prices that crept up at every funding round.
Concentration risk compounds the problem. A typical software engineer at a Series C company might have eighty percent or more of her net worth tied up in a single private security with no current market. If the company stumbles, gets acquired below the latest preferred round, or runs into a down round recapitalization, the equity that looked life-changing on paper can evaporate quickly.
Startup equity liquidity is also a recruiting issue. The strongest candidates increasingly ask about secondary programs, post-termination exercise windows, and company policies on transfer restrictions during the first round of interviews. Companies that handle startup equity liquidity gracefully — even informally — tend to retain their best people longer.
Finally, life happens. Buying a house, paying for a child's education, going through a divorce, or simply diversifying after a decade of equity grants are reasonable goals that almost always require some form of partial liquidity. The question is no longer whether to look at employee liquidity startup options — it's which option fits your situation, your company's policies, and your tax picture.
For a deeper look at why the system creates these problems in the first place, The Problem for Stock & Option Holders is a good companion read.
At the highest level, employees today face five real choices when they think about turning private equity into spendable wealth or diversified exposure:
1. Company-sponsored tender offers and structured secondary programs.
2. Direct sales on private secondary marketplaces such as Forge, Hiive, EquityZen, and Nasdaq Private Market.
3. Option financing — taking outside capital to cover exercise costs and taxes in exchange for sharing future upside.
4. Equity pooling — contributing your shares or options into a vehicle that holds a diversified basket of startup equity.
5. Holding and waiting for an IPO or acquisition.
Each option answers a different question. A tender offer answers, "How do I get cash today at a company-blessed price?" A secondary marketplace answers, "How do I find a buyer when my company isn't running a program?" Option financing answers, "How do I afford to exercise my options without writing a five- or six-figure check?" Equity pooling answers, "How do I diversify out of single-stock risk while still keeping startup upside?"
In my experience, the biggest mistake employees make is treating these as substitutes when they're often complements. A senior engineer at a unicorn might sell twenty percent in a tender offer, finance the exercise of another thirty percent through an option financing provider, pool thirty percent for diversification, and hold the remaining twenty percent for a future IPO. Mixing tools is usually smarter than going all-in on any one of them.
Before you choose, gather four pieces of information: your strike price and current 409A, your exact post-termination exercise window, your company's transfer restriction policy and ROFR clause, and your alternative minimum tax exposure for the year. Without those numbers, comparing these options is guesswork. The free Equity Simulator is a useful starting point if you want to model scenarios before talking to a tax advisor.
A tender offer is the cleanest form of employee liquidity startup access. The company organizes a one-time event in which existing employees can sell a capped percentage of their vested shares to investors at a pre-agreed price. Stripe, Databricks, SpaceX, OpenAI, and many other late-stage companies have run multi-billion-dollar tender offers in recent years, and the cadence has picked up again in 2026 as the IPO window remains narrower than companies would like.
The advantages are real. Pricing is typically tied to a recent primary round, transfer restrictions are waived for the duration of the program, and the tax treatment is well-defined. If you've held the underlying shares long enough, the proceeds can qualify for long-term capital gains rates. The IRS's official guidance on stock options is a reasonable starting point for understanding your specific tax treatment, though every situation requires professional advice.
The disadvantages are also real. Tender offers happen on the company's schedule, not yours. Caps on how much you can sell — typically ten percent to twenty-five percent of vested holdings — limit how much startup equity liquidity you can actually generate. And once you've sold in a tender, the next one may be eighteen months away, or never.
If your company runs tender offers regularly, plan around them. If it doesn't, you'll need to look elsewhere. Many of the best companies are deliberately stingy with secondary windows because they don't want price discovery in the public eye, which is part of why other startup liquidity options for employees have grown so quickly.
Outside of company-organized tenders, employees can sometimes sell on a secondary market. Platforms like Forge, Hiive, EquityZen, and Nasdaq Private Market match accredited buyers with sellers of private company shares. Pricing is opaque and discounts to the last preferred round of twenty to forty percent are not unusual, especially in 2026's more cautious deal environment.
Secondary marketplaces work best when your company explicitly permits transfers, when you hold actual shares (not unexercised options), and when you have enough shares to make the transaction costs worthwhile. Most platforms have minimum transaction sizes and charge meaningful fees on both sides.
The friction is significant. Companies often have a Right of First Refusal (ROFR) and additional transfer restrictions in their bylaws. The SEC's rules and regulations framework — including Rule 144 — defines the holding periods that may apply, and most private companies require explicit approval for any secondary transfer. I've watched deals fall apart in escrow because the company silently exercised its ROFR at the eleventh hour.
For employees who only hold options — not exercised shares — the secondary market is generally closed. You can't sell something you don't yet own. That's where option financing and equity pooling enter the picture. If you want a first-person account of how option financing actually works in practice, the Option Financing Experience post is worth reading before you talk to any provider, and How to Pick a Great Startup frames the broader tradeoffs around evaluating which equity is even worth holding for liquidity in the first place.
The newest categories of startup liquidity options for employees were essentially nonexistent a decade ago. They're built specifically for the structural problems above — illiquidity, concentration risk, exercise costs, and AMT exposure.
Option financing providers advance the cash to exercise your options in exchange for a share of the upside at exit. The structure varies — some providers offer loans against the shares, others use forward contracts, others use participation agreements — but the fundamental tradeoff is the same: you keep the downside protection of having exercised, you avoid writing a check, and you give up a defined slice of the upside if and when the company exits.
Equity pooling is structurally different. Instead of selling or financing one company's shares, you contribute your equity into a pool that holds a diversified basket of startup shares. In return, you receive pro-rata exposure to the entire portfolio. This is the equity equivalent of what index funds did for public markets in the 1970s — it converts a single-name bet into a diversified one without forcing you to sell at a discount today. Introduction to Equity Pooling walks through the mechanics in detail.
The advantage of pooling is that it directly attacks the concentration problem at the heart of the employee liquidity startup challenge. Instead of betting that one specific company succeeds, you bet that a portfolio of high-quality startups, taken together, performs reasonably well — which historically (per long-running benchmarks like those tracked by Cambridge Associates) has been a much better-odds proposition than single-name venture exposure.
Neither tool is perfect. Option financing usually costs more in shared upside than employees expect when they first run the numbers. Equity pooling means giving up the lottery ticket of an individual breakout exit. As with any structured product, read the term sheet carefully, model multiple exit scenarios, and have an independent advisor review the documents before you sign.
Whichever approach you choose, three issues will dominate the math.
Tax treatment is the biggest. Selling ISOs in a tender or secondary can trigger a disqualifying disposition if you haven't held them long enough, converting what should be long-term capital gains into ordinary income. Exercising NSOs creates immediate ordinary income on the spread. Exercising ISOs in a high-income year can pull you into the alternative minimum tax. None of this is fatal — but it's expensive to discover after the fact, and you'll want a qualified CPA who has actually handled startup equity to plan around it.
Risk concentration is the second issue. If you're eighty percent concentrated in a single private security, almost any liquidity action improves your portfolio. The question is which one improves it most for your specific facts. A thirty-year-old early employee with twenty more working years has different needs than a fifty-five-year-old executive eyeing retirement.
Timing is the third. The standard ninety-day post-termination exercise window is the trapdoor that costs employees the most money. If you leave a company with unexercised options and don't act within that window, the options simply disappear. This is the single most common scenario in which employees use option financing — not because they want leverage, but because they don't have two hundred thousand dollars in cash sitting around to write a check on short notice.
For a broader perspective on how this plays into long-term planning, Should I Buy My Equity? is the most comprehensive single resource I've come across on weighing exercise versus walking away.
There is no universal best choice among the startup liquidity options for employees. The right answer depends on your strike price, your tax situation, your remaining exercise window, your company's policies, your overall portfolio concentration, and — honestly — your personal risk tolerance.
A reasonable framework: first, separate "exercise" from "diversify." If your immediate problem is affording to exercise options before they expire, look at option financing. If your problem is too much exposure to one company after you've already exercised, look at tender offers, secondary sales, and equity pooling.
Second, never optimize a single transaction in isolation. The goal is a portfolio outcome over five to ten years, not the maximum cash extracted from any one move. Third, write down your assumptions: if you're modeling a fifty-million-dollar exit in three years, ask yourself how confident you really are in that number, and stress-test the dilution math against a flat or down round.
If you'd like to explore equity pooling specifically — the option that most directly addresses concentration risk for employees who already hold or plan to hold private shares — Aption's team can walk you through how a pool would treat your specific equity. You can get a no-commitment offer to see what the structure looks like for your shares. Either way, the most important thing is to start exploring your startup liquidity options for employees long before you actually need them.
The author name used in this article may be a pen name or pseudonym and is used for illustrative and editorial purposes only. This article is for informational purposes only and does not constitute investment, tax, or legal advice. Consult qualified professionals before making financial decisions. Past performance does not guarantee future results, and any statements about market trends, IPO activity, or specific platforms reflect general industry observations rather than recommendations to buy, sell, or hold any security.
Michael is a financial analyst and equity markets researcher who covers startup valuations, secondary markets, and alternative investment vehicles. He previously led equity research at a top-tier investment bank.